Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Radiodermatitis Market: By Product: Topical, Oral, Dressings; By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments

Global Radiodermatitis Market Outlook

The global radiodermatitis market is projected to grow at a CAGR of 3.7% between 2021 and 2026, to attain USD 570 million by 2026.

 

Global Radiodermatitis Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rise in adoption of Radiotherapy to Propel the Market Growth of Radiodermatitis

The development of the market for radiodermatitis is largely driven by the rise in cancer incidence and the increase in the worldwide use of radiotherapy for recovery. In addition, a surge in the geriatric population is also fueling the demand for radiodermatitis. Further, the increased demand for the elimination of radiation therapy-related side effects is projected to deliver attractive business growth opportunities for radiodermatitis industry over the forecast period.  In the projected timeframe, North America is predicted to be a significant market for radiodermatitis across the globe due to the increasing prevalence of cancer in the US. Growing demand for radiation therapy is also anticipated to be a significant driving force for the North America industry. In Asia-Pacific, rising public and private investment in cancer treatment and healthcare infrastructure is projected to raise the global market for radiodermatitis during the forecast timeframe.

 

Radiodermatitis: Market Segmentation

Radiodermatitis is a cutaneous reaction that, during cancer treatment or often after interventional radiology, occurs as one of the side effects of radiotherapy. It is one of the most frequent side effects of radiation therapy for breast, head and neck cancers, lungs, and soft tissue sarcomas used in carcinoma.

 

Global Radiodermatitis Market By Distribution Channel

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By product, the market is divided into:

  • Topical
  • Oral
  • Dressings

Topical is divided on the basis of type into corticosteroids, hydrophilic creams, antibiotics, among others. Oral segment is bifurcated, based on type, into corticosteroids and oral analgesics and antibiotics. Dressings is divided on the basis of type into hydrogel and hydrocolloid dressing, no sting barrier film, honey impregnated gauze, and silicone coated, among others.

Based on distribution channel, the market is segmented into:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Radiodermatitis Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increase in Prevalence of cancer to Augment the Industry Growth of Radiodermatitis

The increase in cancer cases worldwide is expected to prime the radiodermatitis industry for a stable growth trajectory. There are debilitating side effects of radiation therapy, and radiodermatitis is arguably the worse of the lot. According to the National Institute of Health, it is believed to occur in 85% of cancer patients who are treated with radiation. There is a steadily rising demand from cancer patients for successful palliative care solutions in order to offset the extreme effects of radiation. One of the high impact rendering factors for this sector is the growing number of public and private healthcare organisations actively working to promote awareness about radiodermatitis management and treatment. In addition, these organisations issue guidance and recommendations to treat the disease efficiently, which are expected to broaden the growth potential for the industry over the forecast period. The growing number of clinical trials performed to assess the efficacy of a wide variety of treatment products for radiodermatitis treatment is expected to expand the product pipeline of the market.

 

Key Industry Players in the Global Radiodermatitis Market

The report gives a detailed analysis of the following key players in the global radiodermatitis market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • BMG Pharma S.p.A.
  • Stratpharma AG
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Distribution Channel, Region
Breakup by Product Topical, Oral, Dressings
Breakup by Distribution Channel Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Others
Breakup by Region North America, Latin America, Europe, Middle East and Africa, Asia Pacific
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered BMG Pharma S.p.A., Stratpharma AG, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Radiodermatitis Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Radiodermatitis Historical Market (2017-2021) 
    8.3    Global Radiodermatitis Market Forecast (2022-2027)
    8.4    Global Radiodermatitis Market by Product
        8.4.1    Topical
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    Corticosteroids
                    8.4.1.4.1.1    Market Share
                    8.4.1.4.1.2    Historical Trend (2017-2021)
                    8.4.1.4.1.3    Forecast Trend (2022-2027)
                8.4.1.4.2    Hydrophilic Creams
                    8.4.1.4.2.1    Market Share
                    8.4.1.4.2.2    Historical Trend (2017-2021)
                    8.4.1.4.2.3    Forecast Trend (2022-2027)
                8.4.1.4.3    Antibiotics
                    8.4.1.4.3.1    Market Share
                    8.4.1.4.3.2    Historical Trend (2017-2021)
                    8.4.1.4.3.3    Forecast Trend (2022-2027)
                8.4.1.4.4    Others
        8.4.2    Oral
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
            8.4.2.4    Breakup by Type
                8.4.2.4.1    Corticosteroids
                    8.4.2.4.1.1    Market Share
                    8.4.2.4.1.2    Historical Trend (2017-2021)
                    8.4.2.4.1.3    Forecast Trend (2022-2027)
                8.4.2.4.2    Oral Analgesics and Antibiotics
                    8.4.2.4.2.1    Market Share
                    8.4.2.4.2.2    Historical Trend (2017-2021)
                    8.4.2.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Dressings
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
            8.4.3.4    Breakup by Type
                8.4.3.4.1    Hydrogel and Hydrocolloid Dressing
                    8.4.3.4.1.1    Market Share
                    8.4.3.4.1.2    Historical Trend (2017-2021)
                    8.4.3.4.1.3    Forecast Trend (2022-2027)
                8.4.3.4.2    No Sting Barrier Film
                    8.4.3.4.2.1    Market Share
                    8.4.3.4.2.2    Historical Trend (2017-2021)
                    8.4.3.4.2.3    Forecast Trend (2022-2027)
                8.4.3.4.3    Honey Impregnated Gauze
                    8.4.3.4.3.1    Market Share
                    8.4.3.4.3.2    Historical Trend (2017-2021)
                    8.4.3.4.3.3    Forecast Trend (2022-2027)
                8.4.3.4.4    Silicone Coated
                    8.4.3.4.4.1    Market Share
                    8.4.3.4.4.2    Historical Trend (2017-2021)
                    8.4.3.4.4.3    Forecast Trend (2022-2027)
                8.4.3.4.5    Others
    8.5    Global Radiodermatitis Market by Distribution Channel
        8.5.1    Hospital Pharmacy
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Retail Pharmacy
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Online Pharmacies
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Others
    8.6    Global Radiodermatitis Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    BMG Pharma S.p.A.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
    12.2.2    Stratpharma AG
        12.2.2.1    Company Overview
        12.2.2.2    Product Portfolio
        12.2.2.3    Demographic Reach and Achievements
        12.2.2.4    Certifications
    12.2.3    Others
13    Industry Events and Developments


Additional Customisations Available

1    Manufacturing Process
    1.1    Overview
    1.2    Detailed Process Flow
    1.3    Operation Involved
2    Project Requirement and Cost Analysis
    2.1    Land, Location and Site Development
    2.2    Construction
    2.3    Plant Machinery
    2.4    Cost of Raw Material
    2.5    Packaging
    2.6    Transportation
    2.7    Utilities
    2.8    Manpower
    2.9    Other Capital Investment


List of Key Figures and Tables

1.    Global Radiodermatitis Market: Key Industry Highlights, 2016 and 2026
2.    Global Radiodermatitis Historical Market: Breakup by Product (USD Million), 2017-2021
3.    Global Radiodermatitis Market Forecast: Breakup by Product (USD Million), 2022-2027
4.    Global Radiodermatitis Historical Market: Breakup by Distribution Channel (USD Million), 2017-2021
5.    Global Radiodermatitis Market Forecast: Breakup by Distribution Channel (USD Million), 2022-2027
6.    Global Radiodermatitis Historical Market: Breakup by Region (USD Million), 2017-2021
7.    Global Radiodermatitis Market Forecast: Breakup by Region (USD Million), 2022-2027
8.    North America Radiodermatitis Historical Market: Breakup by Country (USD Million), 2017-2021
9.    North America Radiodermatitis Market Forecast: Breakup by Country (USD Million), 2022-2027
10.    Europe Radiodermatitis Historical Market: Breakup by Country (USD Million), 2017-2021
11.    Europe Radiodermatitis Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Asia Pacific Radiodermatitis Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Asia Pacific Radiodermatitis Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Latin America Radiodermatitis Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Latin America Radiodermatitis Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Middle East and Africa Radiodermatitis Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Middle East and Africa Radiodermatitis Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Global Radiodermatitis Market Structure

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 3.7% between 2021 and 2026.

The industry is being driven by the factors such as the increasing senior population, growing usage of radiotherapy for recovery,rising demand for the eradication of radiation therapy-related side effects, growing number of clinical trials, and rising public and private investment.

The rise in cancer incidences and the expanding number of public and private healthcare organisations actively striving to improve awareness about radiodermatitis management and treatment are the key industry trends propelling the industry forward.

The major regions in the industry are North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.

The products include topical, oral, and dressings.

Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacies, among others.

The major players in the industry are BMG Pharma S.p.A. and Stratpharma AG, among others.

Analyst Review

The global radiodermatitis market has been driven by the rise in cancer cases. Aided by the increasing senior population and the growing number of clinical trials, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 3.7%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The products include topical, oral, and dressings. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacies, among others. The major regional markets for the global radiodermatitis market are North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.. The key players in the above market include BMG Pharma S.p.A. and Stratpharma AG, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER